InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the detailed record of transactions filed by Antoine ULLENS, Director. Insider active across 1 company, notably Octopus Biosafety. Aggregated, 1 filings have been published. Activity tracked since 28 July 2023. The latest transaction was filed on 28 July 2023 (Souscription). Regulator: AMF. All data is openly available.
1 of 1 declaration
Antoine Ullens is a board member at Octopus Biosafety. He participates in the governance of the company, contributing to the definition of strategies and oversight of operations. His expertise in the biotechnology sector is an asset for Octopus Biosafety.